Surgery reduces the risks of death, heart disease, kidney failure, and eye damage more effectively than GLP-1 medicines. A major study conducted at Cleveland Clinic found that individuals with obesity and type 2 diabetes who underwent weight-loss surgery lived longer and experienced fewer serious complications compared with those treated only with GLP-1 receptor agonist drugs. [...]